Renaming PCOS as PMOS will change the lives of women

This article appeared as part of the Daily Sensemaker newsletter – one story a day to make sense of the world. To receive it in your inbox, featuring content exclusive to the newsletter, sign up for free here.

Polycystic ovary syndrome, or PCOS, has been renamed as polyendocrine metabolic ovarian syndrome, or PMOS. The semantic change is important because it more accurately describes a disorder that affects at least 10% of women of reproductive age. It is possible to have polycystic ovary syndrome without polycystic ovaries, while what is relevant is endocrine, metabolic and ovarian dysfunction. This misunderstanding has led to delayed diagnosis and inadequate care for the condition, which can impact weight, metabolism, mental health and the reproductive system. According to the World Health Organization, 70% of women are thought to be unaware that they have the condition. A global consensus of experts announced the name change in The Lancet. NHS officials say it will be “carefully considered”.